Serum sclerostin and risk of hip fracture in older Caucasian women - Wikidata - wikimedia - TriplyDB

Serum sclerostin and risk of hip fracture in older Caucasian women

Serum sclerostin and risk of hip fracture in older Caucasian women

http://www.wikidata.org/entity/Q36069858

about

The Chinese skeleton: insights into microstructure that help to explain the epidemiology of fracture The alliance of mesenchymal stem cells, bone, and diabetes Novel biological markers of bone: from bone metabolism to bone physiology Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease.Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis.Circulating sclerostin associated with vertebral bone marrow fat in older men but not women Marrow fat and bone: review of clinical findings.Increased sclerostin levels after further ablation of remnant estrogen by aromatase inhibitors.Change in estimated glomerular filtration rate and fracture risk in the Action to Control Cardiovascular Risk in Diabetes Trial Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients.Has sclerostin a true endocrine metabolic action complementary to osteocalcin in older men?Serum and tissue biomarkers in aortic stenosis.Sclerostin serum levels in patients with systemic autoimmune diseases Sclerostin Immunoreactivity Increases in Cortical Bone Osteocytes and Decreases in Articular Cartilage Chondrocytes in Aging Mice Sclerostin and bone strength in women in their 10th decade of life.The clinical utility of bone marker measurements in osteoporosis.Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women.Serum sclerostin levels vary with season.Clinical utility of serum sclerostin measurements.Effect of supplemental vitamin D and calcium on serum sclerostin levels.Sclerostin and CKD-MBD.Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder.The Utility of Biomarkers in Osteoporosis Management.Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.Ischemic heart disease is associated with lower cortical volumetric bone mineral density of distal radius.Lower fracture risk in older men with higher sclerostin concentration: a prospective analysis from the MINOS study.The role of sclerostin/dickkopf-1 and receptor activator of nuclear factor kB ligand/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross-sectional study.Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes.Serum Sclerostin Levels in Adults With Osteogenesis Imperfecta: Comparison With Normal Individuals and Response to Teriparatide Therapy.Sclerostin in institutionalized elderly women: associations with quantitative bone ultrasound, bone turnover, fractures, and mortality.High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study.Decreased Plasma Levels of Sclerostin But Not Dickkopf-1 are Associated with an Increased Prevalence of Osteoporotic Fracture and Lower Bone Mineral Density in Postmenopausal Korean Women.Sclerostin Expression in Bile Ducts of Patients With Chronic Cholestasis May Influence the Bone Disease in Primary Biliary Cirrhosis.Is there a role for newer biomarkers in chronic kidney disease-mineral and bone disorder management?Methylation of BoneSOST, Its mRNA, and Serum Sclerostin Levels Correlate Strongly With Fracture Risk in Postmenopausal Women

P2860

Q26863740-DFFD4C1C-0AD2-4AF3-AF4A-61850EE831FE Q27012497-7CEFA60B-ED90-4E9D-9573-0D4E65CE0D54 Q28067712-B12C52D3-9E0E-4205-84FD-4BE2EE2EC7B1 Q30234751-0B112BD8-5356-471F-97AF-84ECF850EB67 Q34537434-AA263B38-9733-4D2B-AB6B-3B0C9F00F730 Q34628276-232F9A55-C310-4593-9200-5736147F862B Q35229131-FD36B175-0874-4FE6-B169-14109AA3DCB4 Q35260816-1DF37612-F1C9-47DA-9F35-8717AE5B0235 Q35739081-5D5EF8F9-2D9C-45A3-B190-97DA9033EA46 Q35885233-98121098-6A13-43DC-AD66-9F7C796ABDD8 Q35967442-AD708695-6E1B-4BE2-9579-EF0059ADC1F7 Q36457058-5585DAA5-8C64-41E9-A83F-3E20372350AD Q36561360-7F61FA60-0283-44FF-AA03-2A0F22E5333C Q36737118-73F659B9-21F5-47CC-8503-7A8D6A5AA224 Q37045961-17391D9B-96B0-4B05-8518-5623487C5D1E Q37153332-43A27731-4DB5-44E3-A12A-F07664B182C3 Q37361795-256FD255-6F5A-4EFA-9D91-44B0ECFEE2AD Q37428939-5C155684-E27A-4AA6-AAA1-7EC4D03C2230 Q37605570-DFAC9758-A9D5-42C2-8FD7-13F948FAC8B2 Q37682879-3CAF38B3-8557-4B0B-BE06-A88E5C978B48 Q38359423-DCF71B82-0C18-4BC5-AFCC-1AF56FC3D1E4 Q38569480-48D3DA37-14AE-4179-8566-B1D90C517043 Q38921875-D9951FF0-14AC-4A0F-84F7-D35ACBF2C1CF Q38970563-E47D9E19-E7B9-4BF3-811A-7E7651BA726C Q38972516-E2C2745A-3F84-4B2B-8D12-4B487A3B66D6 Q39342144-519088B7-9DFF-45F9-812C-CDB52DBEFDB4 Q41023046-9C1CC779-0FD7-4D5E-B8E1-DDD9E5A22260 Q44833234-2CE1C9BD-631B-4993-A721-35ABFA0E5784 Q45875322-3E38C19D-0D65-4A22-97DA-0AB7C0F81E6B Q47327411-5921E9B5-A405-4636-ACB8-8C45A19E5831 Q50088169-FF49B2EA-F691-4E69-B57C-0AE3A57F0D2B Q51142825-D3C8B2BE-2CD7-4FE2-8E71-D075DC5B8F51 Q51189557-3CC2CD9E-FEDD-4192-BD8B-1891B4BE952E Q51707392-E42C76FF-AFE0-43EB-9AEC-569E9B4A7CEC Q53137198-A702AF5E-6A9D-438D-ABB2-166565DDDCB7 Q53342879-76ABCA1A-AEE2-4AA3-9E1B-21D0C59D68FE Q57250831-23922062-51DD-495B-ABC9-DC16B92EF369

P2860

Serum sclerostin and risk of hip fracture in older Caucasian women

http://www.wikidata.org/entity/Q36069858

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Serum sclerostin and risk of hip fracture in older Caucasian women

@ast

Serum sclerostin and risk of hip fracture in older Caucasian women

@en

type

label

Serum sclerostin and risk of hip fracture in older Caucasian women

@ast

Serum sclerostin and risk of hip fracture in older Caucasian women

@en

prefLabel

Serum sclerostin and risk of hip fracture in older Caucasian women

@ast

Serum sclerostin and risk of hip fracture in older Caucasian women

@en

P1433

Q36069858-BAAAB10A-5AFF-4554-80D3-0BB589D902D5

P1476

Q36069858-0506FE3B-778D-4CDF-B6AF-D4E1B555E63C

P2093

Q36069858-16F8E1BE-C72C-41A3-800A-F7A09D9FFCAC

Q36069858-2210BA0C-E98C-4ECF-8649-21B96F2B0E4B

Q36069858-61182CD4-AD25-4DB1-B8FE-4ECFFCAD1F80

Q36069858-83BEBBF5-313E-42DC-9A79-FA99C61D6B78

Q36069858-9E74FA3D-E065-4E88-ACF0-14B645C40BDA

Q36069858-A08A7F01-E29C-45A0-A258-7C8D3AF0F350

Q36069858-D647C8B8-7852-44C1-BD5A-5DDB6D49BFC1

Q36069858-DCF7CEA4-217E-4A02-9848-3C491A0BE0FD

P2860

Q36069858-101DB75E-787C-43C6-A01A-8F842B429FFA

Q36069858-1E53E637-F806-49EF-9AF9-A16003CCAAE3

Q36069858-2777F16C-52B4-44DD-A85D-E05B70B2FEAF

Q36069858-35044C05-FAFC-4BF9-9085-A02FCA84D2B6

Q36069858-379F9A19-34FE-4F67-8113-DD333F1E1CEA

Q36069858-3D44911F-10B6-4CEF-B58F-FAA522831709

Q36069858-504FB401-44D6-40A1-87DB-0C5A69D8580B

Q36069858-6B2357BB-17C1-4C54-87F5-AE3B2FE517D5

Q36069858-731B9AAD-605C-4AE9-A518-7F5F5A0F3A70

Q36069858-7A4DF02A-1DE4-4C18-A0FA-2DE3B5458123

P304

Q36069858-94636A1D-37B2-444D-A99D-60CD13833955

P31

Q36069858-07C00439-82DD-41F4-A418-94EA8879425A

P356

Q36069858-3D97DF42-D3AA-4210-872E-C226D6CC747B

P407

Q36069858-651ACFAB-047C-4D1A-BF3A-B16AB806FE49

P433

Q36069858-F9F9B35E-A5D2-4AF9-8323-CAB1E5F5099D

P478

Q36069858-DA463A95-5ADE-442F-BD5B-02E8B52B2F4A

P50

Q36069858-9C08D9EF-7E39-471A-A8EC-C091EAB15F79

P577

Q36069858-D77AF1D8-9625-4913-8BBF-2A4F9FBFAC01

P698

Q36069858-1D9C2826-A4A8-4DF7-9CA4-5950D1B3BDC5

P932

Q36069858-00E52C9B-043B-4EDD-A0F1-987823746F72

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Serum sclerostin and risk of hip fracture in older Caucasian women

@en

P2093

Aarthi Arasu

http://www.w3.org/2001/XMLSchema#string

Kristine E Ensrud

http://www.w3.org/2001/XMLSchema#string

Li-Yung Lui

http://www.w3.org/2001/XMLSchema#string

Peggy M Cawthon

http://www.w3.org/2001/XMLSchema#string

Puneet S Arora

http://www.w3.org/2001/XMLSchema#string

Steven R Cummings

http://www.w3.org/2001/XMLSchema#string

Study of Osteoporotic Fractures Research Group

http://www.w3.org/2001/XMLSchema#string

Thy P Do

http://www.w3.org/2001/XMLSchema#string

P2860

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor

Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins

Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.

Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease.

P304

2027-2032

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2011-3419

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22466341

http://www.w3.org/2001/XMLSchema#string

P932

3387417

http://www.w3.org/2001/XMLSchema#string